- Home
- CRVS vs OZ Comparison
CRVS vs OZ Comparison
Compare CRVS & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- OZ
- Stock Information
- Founded
- CRVS 2014
- OZ 2020
- Country
- CRVS United States
- OZ United States
- Employees
- CRVS N/A
- OZ N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- CRVS Health Care
- OZ
- Exchange
- CRVS Nasdaq
- OZ Nasdaq
- Market Cap
- CRVS 257.0M
- OZ 236.3M
- IPO Year
- CRVS 2016
- OZ N/A
- Fundamental
- Price
- CRVS $2.99
- OZ $66.00
- Analyst Decision
- CRVS Strong Buy
- OZ
- Analyst Count
- CRVS 5
- OZ 0
- Target Price
- CRVS $12.63
- OZ N/A
- AVG Volume (30 Days)
- CRVS 715.8K
- OZ 24.4K
- Earning Date
- CRVS 05-05-2025
- OZ 01-01-0001
- Dividend Yield
- CRVS N/A
- OZ N/A
- EPS Growth
- CRVS N/A
- OZ N/A
- EPS
- CRVS N/A
- OZ N/A
- Revenue
- CRVS N/A
- OZ $2,675,000.00
- Revenue This Year
- CRVS N/A
- OZ N/A
- Revenue Next Year
- CRVS N/A
- OZ N/A
- P/E Ratio
- CRVS N/A
- OZ N/A
- Revenue Growth
- CRVS N/A
- OZ 18.68
- 52 Week Low
- CRVS $1.30
- OZ $57.01
- 52 Week High
- CRVS $10.00
- OZ $82.89
- Technical
- Relative Strength Index (RSI)
- CRVS 26.38
- OZ 51.48
- Support Level
- CRVS $3.06
- OZ $63.01
- Resistance Level
- CRVS $3.31
- OZ $75.73
- Average True Range (ATR)
- CRVS 0.36
- OZ 2.67
- MACD
- CRVS -0.10
- OZ 0.15
- Stochastic Oscillator
- CRVS 1.11
- OZ 33.76
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.